A Study of BGM0504 in Participants with Type 2 Diabetes

Clinical trial NCT06716216 · RECRUITING

Trial details

NCT number: NCT06716216
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2024-11-29
Primary completion: 2026-03-20
Enrollment: 537

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.